bioMérieux S.A. (BMXMF)
OTCMKTS · Delayed Price · Currency is USD
129.73
+7.18 (5.86%)
May 15, 2025, 4:00 PM EDT

Revenue by Product

Fiscal year is January - December.
Year Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 NaN - NaN
Clinical Applications
3.10B
Log In
Log In
Log In
Log In
Upgrade
Clinical Applications Growth
1.95%
Log In
Log In
Log In
Log In
Upgrade
Industrial Applications
575.30M
Log In
Log In
Log In
Log In
Upgrade
Industrial Applications Growth
4.79%
Log In
Log In
Log In
Log In
Upgrade
Clinical Applications - Microbiology
-
Log In
Log In
Log In
Log In
Upgrade
Clinical Applications - Microbiology Growth
-
Log In
Log In
Log In
Log In
Upgrade
Clinical Applications - Molecular Biology
-
Log In
Log In
Log In
Log In
Upgrade
Clinical Applications - Molecular Biology Growth
-
Log In
Log In
Log In
Log In
Upgrade
Clinical Applications - Immunoessais
-
Log In
Log In
Log In
Log In
Upgrade
Clinical Applications - Immunoessais Growth
-
Log In
Log In
Log In
Log In
Upgrade
Clinical Applications - Other Ranges
-
Log In
Log In
Log In
Log In
Upgrade
Clinical Applications - Other Ranges Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Year Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 NaN - NaN
Americas
1.85B
Log In
Log In
Log In
Log In
Upgrade
Americas Growth
0.26%
Log In
Log In
Log In
Log In
Upgrade
EMEA
964.80M
Log In
Log In
Log In
Log In
Upgrade
EMEA Growth
7.05%
Log In
Log In
Log In
Log In
Upgrade
Asia Pacific
637.70M
Log In
Log In
Log In
Log In
Upgrade
Asia Pacific Growth
2.15%
Log In
Log In
Log In
Log In
Upgrade
France
225.50M
Log In
Log In
Log In
Log In
Upgrade
France Growth
2.64%
Log In
Log In
Log In
Log In
Upgrade
Corporate
900.00K
Log In
Log In
Log In
Log In
Upgrade
Corporate Growth
-65.38%
Log In
Log In
Log In
Log In
Upgrade